Latest filing published 14 Feb 2022 for Chinook Therapeutics, INC..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Alan Glicklich: trading record in brief
This profile gathers the share dealings of Alan Glicklich in Chinook Therapeutics, Inc., where the filings describe the role as senior executive. The record holds 6 filings, for trades running from 16 June 2021 to 11 February 2022.
Sales make up the whole of the open-market record (2 sales, €299k). Other entries cover 1 share grant and 3 option exercises. Since January 2022: no purchases and 1 sale on the market.
The record was last updated on 14 February 2022 with an open-market sale (€27k) in Chinook Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alan Glicklich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,668 sharesCommon StockSEC:0001209191-22-009563:0
- 7,103 sharesCommon StockSEC:0001209191-21-060111:0
- 20,000 shares@ US$0.42100.0% of flowCommon StockSEC:0001209191-21-041646:0
3 of 3 declarations
